US Patent Issued to Vertex Pharmaceuticals on March 17 for "Solid forms of APOL1 inhibitor and methods of using same" (Massachusetts Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,233, issued on March 17, was assigned to Vertex Pharmaceuticals Inc. (Boston).

"Solid forms of APOL1 inhibitor and methods of using same" was invented by Kevin James Gagnon (Acton, Mass.), Jicong Li (Cambridge, Mass.), Ales Medek (Winchester, Mass.), Jack Raphael Minchom (Somerville, Mass.), Yi Shi (Natick, Mass.), Muna Shrestha (Belmont, Mass.) and Faith Witkos (Attleboro, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides novel solid state forms of Compound I selected from ethanol solvate Form A, ethanol solvate Form B, citric acid cocrystal Form A, and Form B, compositions comprising the same, and methods of making and ...